Normal view MARC view ISBD view

M2 [electronic resource]

By:

Lai, Yin-Siew

Contributor(s):

Producer: 20190211Description: 1899-1914 p. digitalISSN:

1793-6853

Subject(s):

Online resources:

Available from publisher's website

In: The American journal of Chinese medicine vol. 46

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

30001 Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
by Bruce, Michael G
30002 Genetic diversity of the HpyC1I restriction modification system in Helicobacter pylori.
by Lehours, Philippe
30003 Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
by Katsinelos, Panagiotis
30004 Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements.
by Brandt, Sabine
30005 Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells.
by Triantafilou, Martha
30006 NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
by Lanas, Angel
30007 Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia.
by Egi, Yasuo
30008 [Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].
by Butorov, I V
30009 Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.
by Cheon, Jae Hee
30010 Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
by Schumann, Christian
30011 Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
by Levine, A
30012 Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
by Kuo, Sung-Hsin
30013 Enzyme immunoassay and immunoblotting analysis of Helicobacter pylori infection in Turkish asymptomatic subjects.
by Abasiyanik, M Fatih
30014 Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
by Horn, J
30015 A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer.
by Nurgalieva, Zhannat Z
30016 Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
by Kokkola, Arto
30017 Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
by Shi, Tong
30018 Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations.
by Ren, Z
30019 Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type.
by Rieder, Gabriele
30020 Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
by Rosaida, Modh Said